Neurogene (NGNE) Asset Utilization Ratio (2019 - 2025)

Neurogene (NGNE) reported Asset Utilization Ratio of 0.0 for Q2 2025, down 38.76% on a YoY basis from 0.0 in Q2 2024, and down 18.41% quarter-over-quarter from 0.0 in Q4 2024.

Neurogene (NGNE) Asset Utilization Ratio (2019 - 2025) Analysis & Trends

Neurogene has reported Asset Utilization Ratio for 4 years, with the latest figure at 0.0 in Q2 2025.

  • For the quarter ending Q2 2025, Asset Utilization Ratio fell 38.76% year-over-year to 0.0; the trailing twelve-month figure through Jun 2025 stood at 0.0 (down 38.76% YoY), and the FY2024 full-year result was 0.0, changed N/A from the prior year.
  • Asset Utilization Ratio for Q2 2025 stood at 0.0, down from 0.0 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 10.89 in Q3 2023, with the low at 0.0 in Q2 2025.
  • Historically, Asset Utilization Ratio has averaged 3.96 across 3 years, with a median of 0.01 in 2024.
  • Annual changes were most pronounced in 2024 — Asset Utilization Ratio tumbled 99.95% — and 2025, when it plunged 38.76%.
  • Neurogene's Asset Utilization Ratio stood at 6.41 in 2023, then slumped by 99.94% to 0.0 in 2024, then fell by 18.41% to 0.0 in 2025.
  • The last three Asset Utilization Ratio figures came in at 0.0 (Q2 2025), 0.0 (Q4 2024), and 0.01 (Q3 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 0.55
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.60
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 1,422.00
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 0.47
9 Abivax 91.96 Bn 91.96 Bn - -
10 Neurogene 216.17 Mn 216.17 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2025 0.00
Dec 31, 2024 0.00
Sep 30, 2024 0.01
Jun 30, 2024 0.00
Dec 31, 2023 6.41
Sep 30, 2023 10.89
Jun 30, 2023 10.39
Sep 30, 2019 14.28